Mark J Edlund1, Valerie L Forman-Hoffman2, Cherie R Winder2, David C Heller2, Larry A Kroutil2, Rachel N Lipari3, Lisa J Colpe4. 1. RTI International, Research Triangle Park, NC 27709-2194, United States. Electronic address: medlund@rti.org. 2. RTI International, Research Triangle Park, NC 27709-2194, United States. 3. Substance Abuse and Mental Health Services Administration, Rockville, MD 20857, United States. 4. National Institute of Mental Health, Bethesda, MD 20892, United States.
Abstract
OBJECTIVE: To investigate the association of major depressive episode (MDE) with nonmedical prescription opioid use (NMPOU) and opioid abuse/dependence among adolescents aged 12 to 17. METHODS: We analyzed 5 years of data from the National Survey on Drug Use and Health (NSDUH). We used logistic regressions to study the relationship between MDE and NMPOU among all adolescents, as well as the relationship of MDE with opioid abuse/dependence among adolescents with NMPOU. Other covariates included: sociodemographics, alcohol abuse/dependence, nonopioid drug abuse/dependence, delinquency, school performance, religious services attendance, and family support/supervision. RESULTS: In the sample of all adolescents, 6% reported past year NMPOU, and 8% reported past year MDE. When NMPOU and MDE were comorbid, MDE usually preceded the NMPOU. In the sample of adolescents with NMPOU, 15% reported past year opioid abuse/dependence, and 20% reported past year MDE. In adjusted logistic regression, MDE was associated with both NMPOU (OR=1.51, p<0.001) among all adolescents and opioid abuse/dependence (OR=2.18, p<0.001) among adolescents with NMPOU. CONCLUSION: MDE occurs commonly in adolescents and is associated with NMPOU and opioid abuse/dependence. In terms of population attributable risk, which is a function of both the prevalence and the strength of the association, MDE is an important risk factor for NMPOU among adolescents and opioid abuse/dependence among adolescents with NMPOU. Preventive and clinical programs to decrease NMPOU and opioid abuse/dependence among adolescents should consider the prominent role of depression.
OBJECTIVE: To investigate the association of major depressive episode (MDE) with nonmedical prescription opioid use (NMPOU) and opioid abuse/dependence among adolescents aged 12 to 17. METHODS: We analyzed 5 years of data from the National Survey on Drug Use and Health (NSDUH). We used logistic regressions to study the relationship between MDE and NMPOU among all adolescents, as well as the relationship of MDE with opioid abuse/dependence among adolescents with NMPOU. Other covariates included: sociodemographics, alcohol abuse/dependence, nonopioid drug abuse/dependence, delinquency, school performance, religious services attendance, and family support/supervision. RESULTS: In the sample of all adolescents, 6% reported past year NMPOU, and 8% reported past year MDE. When NMPOU and MDE were comorbid, MDE usually preceded the NMPOU. In the sample of adolescents with NMPOU, 15% reported past year opioid abuse/dependence, and 20% reported past year MDE. In adjusted logistic regression, MDE was associated with both NMPOU (OR=1.51, p<0.001) among all adolescents and opioid abuse/dependence (OR=2.18, p<0.001) among adolescents with NMPOU. CONCLUSION:MDE occurs commonly in adolescents and is associated with NMPOU and opioid abuse/dependence. In terms of population attributable risk, which is a function of both the prevalence and the strength of the association, MDE is an important risk factor for NMPOU among adolescents and opioid abuse/dependence among adolescents with NMPOU. Preventive and clinical programs to decrease NMPOU and opioid abuse/dependence among adolescents should consider the prominent role of depression.
Authors: Allison Tadros; Shelley M Layman; Stephen M Davis; Rachel Bozeman; Danielle M Davidov Journal: Am J Drug Alcohol Abuse Date: 2016-07-11 Impact factor: 3.829
Authors: Kelly Quinn; Bartley C Frueh; Joy Scheidell; Daniel Schatz; Faith Scanlon; Maria R Khan Journal: Drug Alcohol Depend Date: 2019-02-14 Impact factor: 4.492
Authors: Benjamin A Bouvier; Elizabeth N Kinnard; Jesse L Yedinak; Yu Li; Beth Elston; Traci C Green; Scott E Hadland; Brandon D L Marshall Journal: J Psychoactive Drugs Date: 2019-08-14
Authors: Katherine J Baxter; Jennifer Hafling; Jennifer Sterner; Adarsh U Patel; Helen Giannopoulos; Kurt F Heiss; Mehul V Raval Journal: Pediatr Surg Int Date: 2018-05-04 Impact factor: 1.827
Authors: Sean Esteban McCabe; Philip T Veliz; Carol J Boyd; Ty S Schepis; Vita V McCabe; John E Schulenberg Journal: Drug Alcohol Depend Date: 2018-11-15 Impact factor: 4.492
Authors: Michael G Vaughn; Christopher P Salas-Wright; Kristen P Kremer; Brandy R Maynard; Greg Roberts; Sharon Vaughn Journal: Drug Alcohol Depend Date: 2015-08-21 Impact factor: 4.492